<DOC>
	<DOCNO>NCT01021540</DOCNO>
	<brief_summary>To determine H.P . Acthar Gel ( repository corticotrophin ) anti-proteinuric effect see synthetic ACTH analogue Europe .</brief_summary>
	<brief_title>Prospective Study Evaluating Effect Repository Corticotropin Treatment Various Nephrotic Syndromes</brief_title>
	<detailed_description>Synthetic ACTH ( Synacthen Depot ) use treatment Nephrotic Syndrome Europe . It proven effective treat idiopathic membranous nephropathy various diagnosis involve kidney . However , Synacthen available United States . The preparation available H.P . Acthar Gel ( repository corticotrophin ) widely use treatment infantile spasm available long Synacthen . Therefore , conduct study determine H.P . Acthar Gel ( repository corticotrophin ) effective reduce protein urine see synthetic ACTH Europe .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>Nephrotic Syndrome minimal 3.5grams protein per 24 hr period , measure via either 24hr urine collection spot protein creatinine ratio . Males postmenopausal , surgically sterile , nonlactating nonpregnant female use adequate contraception Biopsy proven diagnosis nephrotic syndrome due Lupus glomerulonephritis , Membranous nephropathy , Focal segmental glomerulosclerosis , Minimal Change disease , Diabetic nephropathy ( type 2 ) IgA nephropathy . Greater 18 year age Willing able give inform consent Diabetics insulin willing start insulin study Previous intolerance native ACTH proteins porcine origin History scleroderma , osteoporosis , systemic fungal infection , ocular herpes simplex , recent surgery , history presence peptic ulcer , primary adrenocortical insufficiency adrenocortical hyperfunction . Expected begin renal replacement therapy receive transplant within next year . Recent cardiovascular event within 3 month screen include : Myocardial Infarction , CVA , TIA , New York Heart Association Functional Class III IV failure , Obstructive valvular heart disease , hypertrophic cardiomyopathy , second third degree atrioventricular block successfully treat pacemaker . History HIV Know peptic ulcer disease . SBP &gt; 160 DBP &gt; 100 time enrollment New diagnosis cancer recurrent cancer within 2 year screen History alcohol drug abuse within 12 month study entry . Receipt investigational drug within 30 day enrollment . Anticipated major surgery trial period Psychiatric disorder interfere patient 's ability comply protocol . Inability cooperate study personnel history noncompliance medical management Active infection within 1 month screen Poorly control diabetes HbA1C &gt; 10 % Type 1 diabetes mellitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Nephritis , Nephropathy</keyword>
</DOC>